“The Bertrand Education Group”

Dr. Bertrand's portfolio has included some start-up companies through angel investments to notable pharmaceutical entities (i.e., Ariad, Bristol Myers Squibb, Arrowhead, etc.). Moreover, he has reinvested his net proceeds by supporting philanthropic initiatives in partnership with local and regional-based organizations to support global humanitarian, education and healthcare consortiums to ensure helping their staff and broader communities in need. 

Most notably, is Dr. Bertrand's commitment to cancer research and innovation, which included a vested interest in various oncology companies, one in particular had two indications for prostate and ovarian cancers inclusive of patients with deleterious BRCA mutation (germline or somatic).

The aforementioned had influenced the Atlas Foundation for Autism to have him serve as Board of Trustee, CNBC (Comcast Company) invitation as an Insights Business Analyst and his alma mater, Columbia University’s Mailman School of Public Health to have him lead an Alumni Panel on “Conflict Resolution.” 

Subsequently, Dr. Bertrand was unanimously selected by St. John's University in partnership with the New York City Department of Education to serve as Distinguished Visiting Lecturer to teach a doctoral level (training) course for teachers, building and district level administrators. The latter objective was to explore challenges, and opportunities that promote culturally relevant learning aligned with equitable healthcare, social and cultural justice for economically disadvantaged municipalities.